Back to Results
First PageMeta Content
Health / Aging-associated diseases / Stem cells / Pre-eclampsia / Cell therapy / Stroke / Eclampsia / Advaxis / Blood pressure / Biology / Medical emergencies / Medicine


Document Date: 2014-03-19 09:50:43

Open Document

File Size: 111,12 KB

Share Result on Facebook

City

Kansas City / /

Company

Pluristem Therapeutics Inc. / Charles River Labs / Boston Biomedica Inc. / MDS Capital Management / PriMed / MdBio / Panacos Inc. / Prosensa Holdings / Bayer Healthcare Receives / /

Country

Japan / /

Event

Business Partnership / /

Facility

University of Missouri / Harvard University / /

IndustryTerm

public pharmaceutical / prevention of stroke / healthcare venture / /

MedicalCondition

Strokes / animal’s high blood pressure / placental-based disorder / obesity / disorder / clinical journal Stroke / preeclampsia doubles / hypertension / disease / stroke / pulmonary hypertension / high blood pressure / uniquely female disease / eclamptic seizures / preeclampsia / hypercholesterolemia / disorders / /

MedicalTreatment

cell therapy / /

Organization

Harvard University / Stroke Center / Wake Forest Baptist Medical Center / University of Missouri / American Stroke Association / Texas A&M / FDA / American Heart Association / Clinical Advisory Board / Stroke Center at Wake Forest Baptist Medical Center / /

Person

William R. Prather / Brent Mitchell / Cheryl Bushnell / Cancer Gold / /

Position

Chair of the committee / physician / Author / CEO / Director / Sr. VP Corporate Development / VP Corporate Development / Registered Pharmacist / animal model / co-founder / /

Product

magnesium sulfate / /

ProvinceOrState

Maryland / Missouri / /

Technology

Cell Therapy / /

URL

http /

SocialTag